Pityriasis lichenoides

Summary

Pityriasis lichenoides (MONDO:0024249) is a disease and 3 clinical trials. A subtype of exanthem — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	pityriasis lichenoides
Mondo ID	MONDO:0024249
MeSH	D017514
ICD-11	266281219
NCIT	C85013
SNOMED CT	200983001
UMLS	C0162853
MedGen	102482
GARD	0010265
Is cancer (heuristic)	no

Also known as: acute Pityriasis Lichenoides · chronic Pityriasis Lichenoides · Pityriasis Lichenoides · pityriasis lichenoides · Pityriasis Lichenoides chronica · Pityriasis Lichenoides et Varioliformis Acuta · Pityriasis Lichenoides, acute · Pityriasis Lichenoides, chronic

Disease family

This is a subtype of exanthem. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › skin disorder › exanthem › pityriasis lichenoides

Related subtypes (12): exanthema subitum, variola major infectious disease, pityriasis versicolor, bacterial exanthem, pityriasis rosea, viral exanthem, prurigo, pityriasis simplex, pityriasis folliculorum, pityriasis amiantacea, pityriasis alba, pityriasis steatoides

Subtypes (1): acute lichenoid pityriasis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06889506	Not specified	NOT_YET_RECRUITING	Interleukin-4 in Pityriasis Lichenoides Chronica
NCT03831269	Not specified	UNKNOWN	Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin
NCT03920696	Not specified	UNKNOWN	Pityriasis Lichenoides : Anatomo-clinical Aspects and Follow-up

Drugs tested across these trials (top 30)

Molecule	Max phase	Trials referencing
CHEMBL4299381	0	1